These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 31435173)

  • 1. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
    Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
    PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
    Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
    Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.
    Attallah AM; Omran MM; Attallah AA; Abdelrazek MA; Farid K; El-Dosoky I
    Int J Clin Oncol; 2017 Apr; 22(2):332-339. PubMed ID: 27864623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on biomarkers of hepatocellular carcinoma.
    Chaiteerakij R; Addissie BD; Roberts LR
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cao L; Cheng H; Jiang Q; Li H; Wu Z
    Aging (Albany NY); 2020 Mar; 12(5):4573-4591. PubMed ID: 32167932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA markers in molecular diagnostics for hepatocellular carcinoma.
    Su YH; Lin SY; Song W; Jain S
    Expert Rev Mol Diagn; 2014 Sep; 14(7):803-17. PubMed ID: 25098554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.
    Lee SC; Tan HT; Chung MC
    World J Gastroenterol; 2014 Mar; 20(12):3112-24. PubMed ID: 24696598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.
    Yin L; He N; Chen C; Zhang N; Lin Y; Xia Q
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1908-1916. PubMed ID: 31072138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Abreu P; Ferreira R; Mineli V; Ribeiro MA; Ferreira FG; DE Mello Vianna RM; Tomasich FDS; Szutan LA
    Anticancer Res; 2020 Dec; 40(12):6573-6784. PubMed ID: 33288552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.